Friday, October 17, 2025 10/17/2025

UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAPS) UG1

Award Number: UG1CA233329
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 03/05/2019
PERIOD OF PERFORMANCE END DATE: 02/28/2026

Group Awards By:

View Award Description

UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAPS) UG1 - PROJECT SUMMARY Clinical trials are an integral part of MD Anderson Cancer Center’s (MDACC) mission. In FY2023, we cared for approximately 179,000 patients and enrolled more than 9,600 patients on nearly 1,500 interventional studies. MDACC has made significant contributions to the former NCI cooperative groups and the new National Clinical Trial Network (NCTN), including robust trial enrollment, scientific and administrative leadership, and mentoring early career faculty to participate in these important national trials. For FY 2019-2024, at MDACC, 1429 patients were enrolled in NCTN Network group clinical trials, including 1081 patients in therapeutic treatment trials resulting in an average of > 200 patients per year. Centralized coordination of NCTN activities at our institution has facilitated the development and conduct of multidisciplinary, innovative trials. This participation has led to opportunities for service through various NCTN leadership roles. Our institution has also sponsored talented clinical and translational investigators to apply for NCTN membership, provided mentorship of early career faculty, and encouraged applications for NCTN peer-reviewed grant funding. These activities have contributed to the success of the NCTN LAPS UG1 grant as well as working towards the fulfillment of our mission of eliminating cancer in Texas, nationally, and globally through advances in cancer treatment, research and education. Our goals will continue with the supplement request of the NCTN LAPS UG1 grant.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $1,404,649 )
2025	2025	THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER	1515 HOLCOMBE BLVD	HOUSTON	TX	77030	HARRIS	USA	Cancer Treatment Research	001	6	8/25/2025	SUPPLEMENT FOR EXPANSION	$517,500
2025	2025	THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER	1515 HOLCOMBE BLVD	HOUSTON	TX	77030	HARRIS	USA	Cancer Treatment Research	000	6	3/12/2025	SUPPLEMENT FOR EXPANSION	$887,149
														Subtotal = $1,404,649

Issue Date FY: 2024 ( Subtotal = $1,404,651 )
2024	2024	THE UNIVERISTY OF TEXAS MD ANDERSON CANCER CENTER, A COMPONENT OF THE UNIVERISTY OF TEXAS SYSTEM	1515 HOLCOMBE BLVD	HOUSTON	TX	77030	HARRIS	USA	Cancer Treatment Research	001	6	4/17/2024	NON-COMPETING CONTINUATION	$73,928
2024	2024	THE UNIVERISTY OF TEXAS MD ANDERSON CANCER CENTER, A COMPONENT OF THE UNIVERISTY OF TEXAS SYSTEM	1515 HOLCOMBE BLVD	HOUSTON	TX	77030	HARRIS	USA	Cancer Treatment Research	000	6	2/27/2024	NON-COMPETING CONTINUATION	$1,330,723
														Subtotal = $1,404,651

Issue Date FY: 2023 ( Subtotal = $1,045,256 )
2023	2023	UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE	1515 HOLCOMBE BLVD	HOUSTON	TX	77030	HARRIS	USA	Cancer Treatment Research	000	5	2/27/2023	NON-COMPETING CONTINUATION	$1,045,256
														Subtotal = $1,045,256

Issue Date FY: 2022 ( Subtotal = $1,911,906 )
2022	2022	UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE	1515 HOLCOMBE BLVD	HOUSTON	TX	77030	HARRIS	USA	Cancer Treatment Research	002	4	8/25/2022	NON-COMPETING CONTINUATION	$433,325
2022	2022	UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE	1515 HOLCOMBE BLVD	HOUSTON	TX	77030	HARRIS	USA	Cancer Treatment Research	001	4	3/2/2022	NON-COMPETING CONTINUATION	$1,478,581
2022	2021	UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER, THE	1515 HOLCOMBE BLVD	HOUSTON	TX	77030	HARRIS	USA	Cancer Treatment Research	000	3	12/23/2021	NON-COMPETING CONTINUATION	$0
														Subtotal = $1,911,906

Issue Date FY: 2021 ( Subtotal = $1,471,041 )
2021	2021	UNIVERSITY OF TEXAS M D ANDERSON CANCER CENTER	1515 HOLCOMBE BLVD UNIT 207	HOUSTON	TX	77030	HARRIS	USA	Cancer Treatment Research	000	3	2/25/2021	NON-COMPETING CONTINUATION	$1,471,041
														Subtotal = $1,471,041

Issue Date FY: 2020 ( Subtotal = $1,478,581 )
2020	2020	UNIVERSITY OF TEXAS M D ANDERSON CANCER CENTER	1515 HOLCOMBE BLVD UNIT 207	HOUSTON	TX	77030	HARRIS	USA	Cancer Treatment Research	001	2	2/28/2020	NON-COMPETING CONTINUATION	$1,478,581
2020	2019	UNIVERSITY OF TEXAS M D ANDERSON CANCER CENTER	1515 HOLCOMBE BLVD UNIT 207	HOUSTON	TX	77030	HARRIS	USA	Cancer Treatment Research	000	1	11/25/2019	NEW	$0
														Subtotal = $1,478,581

Issue Date FY: 2019 ( Subtotal = $1,478,581 )
2019	2019	UNIVERSITY OF TEXAS M D ANDERSON CANCER CENTER	1515 HOLCOMBE BLVD UNIT 207	HOUSTON	TX	77030	HARRIS	USA	Cancer Treatment Research	000	1	3/5/2019	NEW	$1,478,581
														Subtotal = $1,478,581

Grand Total All Awards = $10,194,665

Top

All Categories

About

Search

Reports

Data Submission

Award Information

UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAPS) UG1

Award Number: UG1CA233329

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 03/05/2019

PERIOD OF PERFORMANCE END DATE: 02/28/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer